InspireMD, Inc. (NSPR) Reports Q4 Loss, Tops Revenue Estimates [Yahoo! Finance]
InspireMD Inc. (NSPR)
NASDAQ:AMEX Investor Relations:
inspiremd.com/en/investors/investor-relations
Company Research
Source: Yahoo! Finance
This compares to loss of $0.16 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of 5%. A quarter ago, it was expected that this company would post a loss of $0.20 per share when it actually produced a loss of $0.16, delivering a surprise of 20%. Over the last four quarters, the company has surpassed consensus EPS estimates two times. InspireMD , which belongs to the Zacks Medical - Instruments industry, posted revenues of $1.95 million for the quarter ended December 2024, surpassing the Zacks Consensus Estimate by 6.50%. This compares to year-ago revenues of $1.76 million. The company has topped consensus revenue estimates three times over the last four quarters. The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call. InspireMD shares have added about 6.1%
Show less
Read more
Impact Snapshot
Event Time:
NSPR
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NSPR alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NSPR alerts
High impacting InspireMD Inc. news events
Weekly update
A roundup of the hottest topics
NSPR
News
- Landmark CREST-2 Study Published in the New England Journal of Medicine Highlights the Benefits of Carotid Artery StentingGlobeNewswire
- InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) [Yahoo! Finance]Yahoo! Finance
- InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)GlobeNewswire
- InspireMD to Participate in Upcoming Piper Sandler 37th Annual Healthcare ConferenceGlobeNewswire
- InspireMD Reports Third Quarter 2025 Financial ResultsGlobeNewswire
NSPR
Earnings
- 11/4/25 - In-Line
NSPR
Sec Filings
- 12/11/25 - Form 4
- 12/8/25 - Form 4
- 12/5/25 - Form 4
- NSPR's page on the SEC website